Report of Foreign Issuer (6-k)
September 21 2020 - 8:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2020 (No. 1)
Commission File Number 001-37846
CELLECT BIOTECHNOLOGY LTD.
(Translation of registrant’s name
into English)
23 Hata’as
Street
Kfar Saba, Israel
44425
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
The press release attached hereto as
Exhibit 99.1 entitled “Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa: Management to
Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business
Collaborations” is hereby incorporated by reference into the Registrant’s Registration Statements on Form S-8
(Registration Nos. 333-214817, 333-220015, 333-225003 and 333-232230) and on Form F-3 (Registration No. 333-219614).
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Date: September 21, 2020
|
|
CELLECT BIOTECHNOLOGY, LTD.
|
|
|
|
|
|
|
By:
|
/s/ Eyal Leibovitz
|
|
|
|
Eyal Leibovitz
|
|
|
|
Chief Financial Officer
|
2
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Jul 2023 to Jul 2024